Press
Coverage of our research and the wider antivenom crisis.
South Africa's National Health Laboratory Service completely ran out of snake, scorpion, and spider antivenom, highlighting the urgency of alternative production methods.
The Daily Maverick reported that NHLS stock of all antivenom types dropped to zero in early 2025, following extended production suspensions at SAVP due to facility renovations and infrastructure failures exacerbated by load-shedding.
Read article →
The Loof Foundation announces a partnership with Snake Pharm to advance snakebite prevention and treatment in rural KwaZulu-Natal.
The Loof Foundation facilitated an introductory meeting between Thanda Game Reserve and Donald Schultz from Snake Pharm, exploring collaboration on community snakebite prevention and education programs in the Zululand region.
Read article →
Donald Schultz's biomimicry approach to antivenom production could produce treatment in approximately one hour at a fraction of the cost of traditional methods.
Coverage of Snake Pharm's antivenom research method, detailing the biomimicry approach using ophiophagous snake blood plasma. The article covers production specs, anticipated pricing, and the facility plans for KwaZulu-Natal.
Read article →For press requests, interviews, or filming access, contact us directly.
snakepharmsa@outlook.comOccasional updates. Research, trials, new videos.
Our Partners
